AstraZeneca announces new deals with biotechs

02/1/2007 | Bloomberg · Reuters

AstraZeneca said it will acquire U.K. biotech company Arrow Therapeutics for $150 million to boost research on bacteria and virus compounds, a day after announcing two licensing agreements worth $800 million to develop obesity and respiratory drugs. The drugmaker also announced plans to cut 3,000 jobs.

View Full Article in:

Bloomberg · Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ